BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28883023)

  • 1. Time to consider a targeted HPV vaccination programme for male military recruits.
    Sharp WMJ; Nadarzynski T; Dufty NE
    J R Army Med Corps; 2018 Aug; 164(4):284-286. PubMed ID: 28883023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attendance of MSM at Genitourinary Medicine services in England: implications for selective HPV vaccination programme (a short communication).
    Bayley J; Mesher D; Nadarzynski T; Hughes G; Soldan K
    Sex Transm Infect; 2018 Nov; 94(7):542-544. PubMed ID: 28280237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination for Human Papillomavirus: Immunization Practices in the U.S. Military.
    Buechel JJ
    Clin J Oncol Nurs; 2018 Feb; 22(1):104-107. PubMed ID: 29350712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnel.
    Masel J; Deiss RG; Wang X; Sanchez JL; Ganesan A; Macalino GE; Gaydos JC; Kortepeter MG; Agan BK
    Sex Transm Dis; 2015 May; 42(5):253-8. PubMed ID: 25868137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus (HPV): making the case for 'Immunisation for All'.
    Prue G; Lawler M; Baker P; Warnakulasuriya S
    Oral Dis; 2017 Sep; 23(6):726-730. PubMed ID: 27492979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee.
    Sauvageau C; Dufour-Turbis C
    Hum Vaccin Immunother; 2016 Jun; 12(6):1560-5. PubMed ID: 26554731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention strategies against human papillomavirus in males.
    Garland SM
    Gynecol Oncol; 2010 May; 117(2 Suppl):S20-5. PubMed ID: 20138347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER;
    MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with men.
    Forster AS; Gilson R
    Hum Vaccin Immunother; 2019; 15(7-8):1541-1543. PubMed ID: 30570380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccines against human papillomavirus (HPV); between registration and implementation].
    van Rossum TG; de Melker HE; Houweling H; Voordouw AC; Meijer CJ; Helmerhorst TJ; Kretzschmar M; Berkhof J; van der Noordaa J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):987-92. PubMed ID: 18549172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expanded Impact of Human Papillomavirus Vaccine.
    Pahud BA; Ault KA
    Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting HPV prevention in the school setting.
    Bellia-Weiss T; Parsons M; Sebach AM; Rockelli LA
    NASN Sch Nurse; 2013 Mar; 28(2):86-93. PubMed ID: 23600092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
    Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
    Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services.
    Sacks RJ; Copas AJ; Wilkinson DM; Robinson AJ
    Sex Transm Infect; 2014 Jun; 90(4):315-21. PubMed ID: 24636998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of general human papillomavirus vaccination in sexually active women].
    Hampl M
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S95-9. PubMed ID: 19353480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?
    Low GM; Attiga YS; Garg G; Schlegal R; Gallicano GI
    Viral Immunol; 2012 Jun; 25(3):174-86. PubMed ID: 22691099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
    Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
    Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One decade of HPV vaccination in Germany].
    Schneede P
    Urologe A; 2017 Jun; 56(6):728-733. PubMed ID: 28455577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.